The fuse was lit when the powerful U.S. pharmaceutical industry faced a rare and unexpected setback in the summer of 2022 when President Joe Biden signed the Inflation Reduction Act (IRA) into law.
In August 2023, the Department of Health and Human Services (HHS) named the 10 drugs covered under Medicare Part D targeted for the first round of negotiations between government and industry.
#drug-industry #government #medicare-price-negotiations #inflation-reduction-act #pharmaceutical-industry
[
add
]
[
|
|
...
]